1. Background
2. Objectives
3. Patients and Methods
3.1. S. aureus Isolation
3.2. DNA Extraction and PCR of spa
3.3. PCR RFLP
3.4. Statistical Analysis
4. Results
| Type | 1 | 2 | 3 | 4 | 5 | 6 | 7 | Total |
|---|---|---|---|---|---|---|---|---|
| Carrier b | 17 (32.1) | 11 (20.8) | 17 (32.1) | 7 (13.2) | 0 | 0 | 1 (1.9) | 53 (100.0) |
| Patient | 33 (44.0) | 26 (34.7) | 4 (5.3) | 10 (13.3) | 1 (1.3) | 1 (1.3) | 0 | 75 (100.0) |
| Total | 50 (39) | 37 (28.9) | 21 (16.4) | 17 (13.3) | 1 (0.8) | 1 (0.8) | 1 (0.8) | 128 (100) |
a Data are presented in No. (%).
b P value of the spa types between carriers and patients was = 0.003.
| Type | 1 | 2 | 3 | 4 | 5 | 6 | 7 | Total |
|---|---|---|---|---|---|---|---|---|
| MSSA c | 38 (45.8) | 13 (15.7) | 20 (24.1) | 9 (10.8) | 1 (1.2) | 1 (1.2) | 1 (1.2) | 83 (100.0) |
| MRSA | 12 (26.7) | 24 (53.3) | 1 (2.2) | 8 (17.8) | 0 | 0 | 0 | 45 (100.0) |
| Total | 50 (39) | 37 (28.9) | 21 (16.4) | 17 (13.3) | 1 (0.8) | 1 (0.8) | 1 (0.8) | 128 (100) |
a Abbreviations: MRSA, methicillin-resistant S. aureus; MSSA, methicillin-sensitive S. aureus.
b Data are presented in No. (%).
c P value of the spa types between MRSA and MSSA was < 0.001.
| Type | Urine | Wound | Blood | Others b | Total |
|---|---|---|---|---|---|
| 1 | 12 (36.3) | 4 (12.1) | 6 (18.1) | 11 (33.3) | 33 (100) |
| 2 | 6 (23.1) | 7 (26.9) | 9 (34.6) | 4 (15.3) | 26 (100) |
| 3 | 0 | 3 (75) | 0 | 1 (25) | 4 (100) |
| 4 | 5 (50) | 1 (10) | 2(20) | 2 (20) | 10 (100) |
| 5 | 0 | 1 (100) | 0 | 0 | 1 (100) |
| 6 | 1 (100) | 0 | 0 | 0 | 1 (100) |
| 7 | 0 | 0 | 0 | 0 | 0 |
| Total | 24 (32) | 16 (12.5) | 17 (12.9) | 18 (13.6) | 75 (100) |
a Data are presented in No. (%).
bS. aureus isolated from other samples such as: synovial fluid, CSF, sputum, throat culture, and stool culture.
